We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.

Delisted

AMPE was delisted on the 12th of April, 2024.

110 hedge funds and large institutions have $51.5M invested in Ampio Pharmaceuticals Inc. in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more call options, than puts

Call options by funds: $2.19M | Put options by funds: $695K

133% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 15

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

29% more capital invested

Capital invested by funds: $40M → $51.5M (+$11.5M)

7% more funds holding

Funds holding: 103110 (+7)

Holders
110
Holders Change
+7
Holders Change %
+6.8%
% of All Funds
1.93%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
35
Reduced
15
Closed
9
Calls
$2.19M
Puts
$695K
Net Calls
+$1.49M
Net Calls Change
+$1.18M
Name Holding Trade Value Shares
Change
Change in
Stake
SFS
26
Strategic Financial Services
New York
$321K
CSS
27
Cubist Systematic Strategies
Connecticut
$314K +$297K +575 +1,278%
Morgan Stanley
28
Morgan Stanley
New York
$260K +$86.6K +168 +49%
CPIG
29
Chicago Partners Investment Group
Illinois
$240K +$4.64K +9 +2%
Osaic Holdings
30
Osaic Holdings
Arizona
$212K +$516 +1 +0.2%
HIS
31
Harvest Investment Services
Illinois
$210K
LP
32
LMR Partners
United Kingdom
$192K +$196K +380 New
T. Rowe Price Associates
33
T. Rowe Price Associates
Maryland
$191K -$77.4K -150 -28%
CAPTRUST Financial Advisors
34
CAPTRUST Financial Advisors
North Carolina
$189K +$96.4K +187 +101%
CC
35
Chicago Capital
Illinois
$187K +$190K +369 New
Bank of New York Mellon
36
Bank of New York Mellon
New York
$179K -$19.1K -37 -10%
GIA
37
GHP Investment Advisors
Colorado
$152K
GWM
38
Geneos Wealth Management
Colorado
$127K
Charles Schwab
39
Charles Schwab
California
$124K
CCB
40
Cutter & Co Brokerage
Missouri
$116K
DIA
41
Dana Investment Advisors
Wisconsin
$110K
LPL Financial
42
LPL Financial
California
$106K -$9.28K -18 -8%
TCM
43
Traynor Capital Management
Pennsylvania
$103K -$86.6K -168 -45%
RJFSA
44
Raymond James Financial Services Advisors
Florida
$98K +$1.03K +2 +1%
State Street
45
State Street
Massachusetts
$95K
UCFA
46
United Capital Financial Advisors
Texas
$94K +$1.03K +2 +1%
TWM
47
Tradition Wealth Management
Minnesota
$86K +$1.03K +2 +1%
DC
48
Diametric Capital
Massachusetts
$76K +$77.4K +150 New
IWM
49
IHT Wealth Management
Illinois
$74K +$5.16K +10 +7%
Balyasny Asset Management
50
Balyasny Asset Management
Illinois
$69K +$70.1K +136 New

AMPE Hedge Fund Activity: Q1 2021 in Review

110 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2021, worth a combined $51.5M — up 29% from $40M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AMPE positions and 9 closed out — a net gain of 9 holders — while 35 added to existing stakes and 15 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.81M. The largest seller was Group One Trading, cutting an estimated $286K.

  • 110 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2021, up from 103 in Q4 2020.
  • Funds reported $51.5M of Ampio Pharmaceuticals Inc. stock for Q1 2021, up 29% quarter-over-quarter.
  • 18 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2021 and 9 closed out, a net change of +9 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q1 2021 was Millennium Management, an estimated $2.81M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q1 2021 was Group One Trading, an estimated $286K sold.

Based on aggregated 13F filings for Q1 2021.